{"id":"W4231347798","doi":"10.1016/j.jval.2018.09.2440","title":"PRS46 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Exacerbation; Internal medicine; Incremental cost-effectiveness ratio; Cost effectiveness; Quality-adjusted life year; Corticosteroid","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005542918,0.000764461,0.001422182,0.0005006713,0.0005955643,0.002035994,0.0009512741,0.001146372,0.006096577],"category_scores_gemma":[0.008898809,0.0002824398,0.004235771,0.001136653,0.0006128312,0.0008926321,0.000964074,0.001523724,0.0002178456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02549275,"about_ca_system_score_gemma":0.03085065,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7757133,"about_ca_topic_score_gemma":0.7756491,"domain_scores_codex":[0.9958237,0.002794971,0.0001553774,0.000270946,0.0004256963,0.0005292379],"domain_scores_gemma":[0.9961482,0.001756922,0.0006146658,0.0001188712,0.0006049938,0.0007563577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2018175,0.008950645,0.1967009,0.005689831,0.01578796,0.0004513548,0.0005348237,0.1452047,0.002211199,0.005348948,0.01514103,0.4021612],"study_design_scores_gemma":[0.09157144,0.06559469,0.5923942,0.003582245,0.02219113,0.0003985752,0.001874596,0.2019337,0.001938868,0.002381372,0.01577318,0.0003662072],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9637249,0.01044878,0.001299078,0.004898746,0.0001498941,0.001623363,0.008412493,0.00006709583,0.00937564],"genre_scores_gemma":[0.9937756,0.001648174,0.0015053,0.0004303557,0.00002856014,0.000200693,0.00156903,0.000006170901,0.0008360925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2242867,"threshold_uncertainty_score":0.4512152,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06086374867764698,"score_gpt":0.3487205623077205,"score_spread":0.2878568136300735,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}